x
CME-Tagline

Breaking Down the Barrier of HIV-Related Stigma: Health Care Disparities and Unconscious Bias

CMEO Podcast

Premiere Date: Friday, April 1, 2022

This activity will offer CE credit for:

  1. Pharmacy (acpe)

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Creditâ„¢

Credit Expiration Date: Saturday, April 1, 2023

Faculty


Dan Scales, PharmD, AAHIVP Dan Scales, PharmD, AAHIVP (Moderator)
Director of Pharmacy Collaborative Care
Vivent Health
Denver, CO

Christina M. Madison, PharmD, FCCP, AAHIVP Christina M. Madison, PharmD, FCCP, AAHIVP 
Founder and CEO, The Public Health Pharmacist, PLLC
Associate Professor of Pharmacy Practice
Roseman University of Health Sciences, College of Pharmacy
Las Vegas, NV

Statement of Need

Despite remarkable advances in HIV treatment and prevention, HIV continues to spread at epidemic levels in the United States. Pre-exposure prophylaxis (PrEP) remains underutilized, with large rates of gender identity and race/ethnicity prescribing disparities. The 2021-2025 HIV National Strategic Plan identified HIV-related stigma in health care as a primary barrier hindering patients from seeking HIV prevention services. As part of the health care team, pharmacists need to recognize these inadvertent behaviors and ideologies, such as homophobia, transphobia, racism, and negative views of lifestyle choices, that impede initiation of PrEP and HIV prevention strategies.

In part 1 of this CMEO podcast series, Breaking Down the Barrier of HIV-Related Stigma: Health Care Disparities and Unconscious Bias, join Drs. Dan Scales and Christina Madison as they discuss how pharmacists can overcome implicit bias in health care and support equitable PrEP access for all patients.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Recognize health care disparities and unconscious bias associated with HIV-related stigma in reference to race, gender, and identity.

Financial Support

Supported by an educational grant from Gilead Sciences, Inc. This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the developmental content or selection of faculty for this educational activity.

Target Audience

Pharmacists

Credit Information

Specific CE Credit information is not available at this time. Please check again soon!

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Scales reports no financial relationships.

Dr. Madison reports the following financial relationships:

Speakers Bureau: Gilead Sciences, Inc. and Janssen Pharmaceuticals, Inc.

The following peer reviewer and CME Outfitters Staff have no financial relationships:

  • Michael Franks, APRN, AGACNP-BC, FNP-BC (peer reviewer)
  • Kellie Busby, PharmD (planning committee)
  • Julie Strickland, PharmD (planning committee)
  • Susan Perry (planning committee)
  • Susan H. Yarbrough, CHCP (planning committee)
  • Sharon Tordoff (planning committee)


  • Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

    Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


    This document was last modified on:

    PD-081-040122-90